Outcomes for individual disease groups and whole group completers
| CRD n=127 | CHF n=37 | Whole Group n=164 | |||||||
| Pre mean (SD) | Post mean (SD) | Change mean (95% CI) | Pre mean (SD) | Post mean (SD) | Change mean (95% CI) | Pre mean (SD) | Post mean (SD) | Change mean (95% CI) | |
| ISWT (m) | 231.8 (±138.0) | 277.5 (±150.6) | 45.6 (33.0 to 58.2)*c | 205.8 (±121.5) | 258.9 (±154.6) | 53.1 (20.5 to 85.6)*c | 225.6 (±134.3) | 273.0 (±151.3) | 47.4 (35.3 to 59.5)*c |
| ESWT (s) | 201.6 (±120.5) | 510.1 (±429.2) | 308.5 (239.5 to 377.5)*c | 249.5 (±220.7) | 570.8 (±333.6) | 321.3 (183.6 to 459.0)* | 209.7 (±142.8) | 520.4 (±414.1) | 310.7 (249.4 to 371.9)* |
| QMVC (kg) | 21.9 (±10.5) | 25.7 (±10.5) | 3.7 (2.1 to 5.4)* | 20.8 (±7.7) | 24.4 (±7.3) | 3.6 (1.8 to 5.4)* | 21.8 (±10.1) | 25.5 (±10.1) | 3.7 (2.3 to 5.2)* |
| HADS-A | 7.4 (±4.3) | 6.0 (±4.0) | −1.5 (−2.0 to −0.9)*c | 6.5 (±4.4) | 4.5 (±4.1) | −2.1 (−3.2 to −1.0)*c | 7.3 (±4.3) | 5.7 (±4.0) | −1.6 (−2.1 to −1.1)*c |
| HADS-D | 6.5 (±3.6) | 5.7 (±4.0) | −0.8 (−1.2 to −0.3)* | 6.8 (±3.5) | 3.7 (±3.0) | −3.0 (−4.5 to −1.6)* | 6.6 (±3.6) | 5.3 (±3.9) | −1.3 (−1.7 to −0.8)* |
| CRQ/CHQ - SR -dyspnoea | 2.1 (±1.4) | 2.5 (±1.9) | 0.4 (0.1 to 0.6)* | 4.0 (±1.4) | 4.7 (±1.1) | 0.7 (−0.9 to 2.3) | 2.2 (±1.5) | 2.6 (±2.0) | 0.4 (0.1 to 0.6) * |
All values are mean (±SD) unless otherwise stated.
*p≤0.0001; C: clinically relevant (meets minimal clinically important difference for this population).
CHF, chronic heart failure; CRD, chronic respiratory disease; CRQ/CHQ - SR - dyspnoea, Chronic Respiratory Questionnaire/Chronic Heart Questionnaire - self reported - dyspnoea domain; ESWT, endurance shuttle walking test; HADS-A, Hospital Anxiety and Depression Score – anxiety; HADS-D, Hospital Anxiety and Depression Score – depression; ISWT, incremental shuttle walking test; kg, kilograms; m, metres; QMVC, Quadriceps maximal Voluntary Contraction.;